CANNITO, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 6.364
AS - Asia 3.814
EU - Europa 3.606
OC - Oceania 149
SA - Sud America 114
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 9
Totale 14.125
Nazione #
US - Stati Uniti d'America 6.167
CN - Cina 2.077
IT - Italia 953
SG - Singapore 454
DE - Germania 411
IE - Irlanda 402
SE - Svezia 382
GB - Regno Unito 287
FR - Francia 245
HK - Hong Kong 243
KR - Corea 238
FI - Finlandia 234
JP - Giappone 227
CA - Canada 171
AU - Australia 144
IN - India 132
UA - Ucraina 132
ES - Italia 111
TW - Taiwan 99
PL - Polonia 95
VN - Vietnam 88
ID - Indonesia 66
AT - Austria 62
BR - Brasile 61
NL - Olanda 58
IR - Iran 54
EG - Egitto 42
CL - Cile 35
PK - Pakistan 35
TR - Turchia 33
BE - Belgio 32
DK - Danimarca 29
GR - Grecia 26
RU - Federazione Russa 26
CH - Svizzera 25
RO - Romania 24
MX - Messico 22
BY - Bielorussia 17
AR - Argentina 12
IL - Israele 12
PT - Portogallo 12
MY - Malesia 10
RS - Serbia 10
CZ - Repubblica Ceca 9
EU - Europa 9
IQ - Iraq 9
SN - Senegal 9
ZA - Sudafrica 9
NO - Norvegia 6
TH - Thailandia 6
BG - Bulgaria 5
MO - Macao, regione amministrativa speciale della Cina 5
AE - Emirati Arabi Uniti 4
LB - Libano 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
LT - Lituania 3
PE - Perù 3
PH - Filippine 3
BN - Brunei Darussalam 2
CM - Camerun 2
GH - Ghana 2
HN - Honduras 2
LU - Lussemburgo 2
AL - Albania 1
AO - Angola 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
LK - Sri Lanka 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
WS - Samoa 1
ZM - Zambia 1
Totale 14.125
Città #
Chandler 722
Beijing 610
Dublin 395
Singapore 370
Fairfield 358
Ann Arbor 331
Santa Clara 305
Ashburn 266
Torino 261
Houston 251
Seattle 230
Shanghai 224
Woodbridge 190
Wilmington 164
Redwood City 163
Jacksonville 140
Nyköping 133
Guangzhou 121
Villeurbanne 121
Columbus 120
Cambridge 118
Dearborn 108
Princeton 107
Medford 104
Pisa 96
Brisbane 92
Nanjing 91
Montréal 89
Taipei 82
Warsaw 80
Boston 76
Xian 70
Milan 67
Munich 61
Düsseldorf 55
Dong Ket 54
Central 53
Jakarta 52
Boardman 48
Hangzhou 48
Turin 48
Wuhan 48
Vienna 45
Fremont 43
Mcallen 43
Zhengzhou 43
Hefei 41
Jinan 41
Florence 40
Chengdu 39
Tokyo 39
Washington 36
New York 35
Santiago 33
Fuzhou 32
Shenyang 32
Barcelona 29
Hong Kong 28
Rome 28
San Diego 27
Changsha 25
Helsinki 24
Ottawa 24
Brussels 23
Central District 22
London 21
Seoul 21
Tianjin 21
Padova 20
Chongqing 19
Madrid 19
Pittsburgh 19
Changchun 18
Kunming 18
Los Angeles 17
New Delhi 17
Norwalk 17
Jena 16
Andrésy 15
Mountain View 15
Nanchang 15
Sydney 15
Renton 14
San Mateo 14
Silver Spring 14
Toronto 14
Delhi 13
Falls Church 13
Cairo 12
Lappeenranta 12
Mexico 12
Paris 12
Phoenix 12
Amsterdam 11
Bengaluru 11
Harbin 11
Nanning 11
Philadelphia 11
Tucson 11
Lahore 10
Totale 8.415
Nome #
Liver fibrosis: a dynamic and potentially reversible process. 1.116
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein. 667
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 617
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS 601
Cellular And Molecular Mechanisms In Liver Fibrogenesis. 566
Hypoxia, hypoxia inducible factors and fibrogenesis in chronic liver diseases 528
Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases 441
Hyaluronated mesoporous silica nanoparticles for active targeting: influence of conjugation method and hyaluronic acid molecular weight on the nanovector properties 412
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 358
Effects of the rare elements lanthanum and cerium on the growth of colorectal and hepatic cancer cell lines 290
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. 287
Angiogenesis and liver fibrogenesis 251
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells 247
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 194
Therapeutic pro-fibrogenic signaling pathways in fibroblasts 192
CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways 191
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. 189
Liver fibrogenesis: un update on established and emerging basic concepts 188
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 185
SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells 177
Hypoxia-inducible factor 2alpha drives the progression of experimental non-alcoholic fatty liver disease by stimulating hepatocyte production of histidine rich glycoprotein 176
Hepatic myofibroblasts: a heterogenous population of multifunctional cells in liver fibrogenesis 175
Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components 142
VEGF ed Angiopoietina-1: fattori ipossia- e leptina-dipendenti capaci di indurre migrazione e chemiotasssi in cellule stellate epatiche umane 138
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. 135
4-Idrossinonenale come stimolo pro-fibrogenico selettivo per le cellule stellate umane attivate 134
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity. 133
In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future? 126
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells. 123
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells 111
SERPIN-B3 can contribute to fibrogenic progression of chronic liver diseases towards cirrhosis and HCC development 102
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 101
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. 96
Oncostatin M, overexpressed in hepatocellular carcinoma, up-regulates SERPIN-B3 expression in hepatic cancer cells 95
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 95
Chemotaxis in Profibrogenic Human Hepatic Stellate Cells Requires Redox – Dependent Activation of c-Jun N-Terminal Kinase Isoforms 1 and 2 95
Hypoxia – induced migration of human hepatic stellate cellsrequires an early and redox sensitive activation of c-Jun N-terminal kinase 94
Common signalling events regulate migration and chemotaxis of hepatic stellate cells and bone marrow – derived mesenchymal stem cells 92
Oncostatin M stimulates directional migration of human hepatic pro-fibrogenic cells. 92
Oncostatin M stimulates chemotaxis of human hepatic profibrogenic cells 91
Bcl-2 overexpression in human activated hepatic stellate cells: a survival and pro-fibrogenic mechanism 90
Common signalling and redox sensitive events regulate migration and chemotaxis of bone marrow – derived mesenchymal stem cells and hepatic stellate cells. 90
Hypoxia - induced migration of human hepatic stellate cells requires an early and redox sensitive activation of c-jun n-terminal kinase 89
NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2 alpha 88
Beta-catenin triggers nuclear factor kB - dependent up-regulation of hepatocyte inducible nitric oxide synthase 87
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 87
Hypoxia drives epithelial mesenchymal transition in neoplastic cells of the gastro-intestinal tract: a beta-catenin and snail–mediated event favouring migration and/or invasiveness 86
Hepatic myofibroblasts: origin and role in liver fibrogenesis 85
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 84
Serpinb3 is overexpressed in the liver in presence of iron overload 83
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 83
PDGF-BB is an effective mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 82
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 82
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice 81
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential 81
Bone Marrow – Derived Mesenchymal Stem Cells Engraft Chronically Injured Liver and Differentiate Into Pro-fibrogenic Myofibroblast-Like Cells: the Role of PDGF-BB 79
Cytokine – induced migration of human hepatic stellate cells requires activation of c-jun n-terminal kinase and intracellular generation of reactive oxygen species 78
Positive correlation of HIF2alpha and serpinB3 in human hepatocellular carcinoma: selective and prognostic implications 78
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts. 77
Silencing of Bcl-2 expression in human hepatic stellate cells turns off their survival attitude 76
Sopravvivenza all’induzione di apoptosi in cellule stellate epatiche umane attivate: un’attitudine pro-fibrogenica 76
A Cla response of Human Breast cancer cells: mechanisms involved 76
Redox-sensitive GSK-3 inhibition and late VEGF release mediate hypoxia – dependent epithelial mesenchymal transition and increased invasiveness in human HepG2 cells 75
Cytoskeletal rearrangement by the mitogen-activated protein kinaseERK5 interferes with the motile and invasive phenotype ofhepatocellular carcinoma cells 75
HIF2alpha neddylation as a selective serpinb3-dependent mechanism leading to its increased stabilization and nuclear translocation in liver cancer cells 75
Hypoxia and angiogenesis in the progression of chronic liver diseases towards cirrhosis and hepatocellular carcinoma. 71
Epithelial – mesenchymal transition in human hepatocellular carcinoma cells under hypoxia: a beta catenin and SNAIL – mediated event favouring migration and/or invasiveness 70
Hepatocyte-derived microparticles promote NLRP3 inflammasome activation in HepG2 cells 70
Survival and phenotypic responses of fully activated human hepatic stellate cells to superoxide and TNF: critical role of generation rate and Bcl-2 levels 69
Intracellular redox changes and c- jun n-terminal kinase as crucial events in cytokine – induced chemotaxis of human activated hepatic stellate cells 69
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells. 67
Dose-dependent and divergent effects of superoxide anion on cell death, proliferation and migration of activated human hepatic stellate cells 66
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 66
Redox-dependent induction of epithelial to mesenchymal transition and increased invasiveness by oncostatin M in hepatic cancer cells. 66
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells 66
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS 64
GPR21 inhibition increases glucose-uptake in HepG2 cells 64
Redox-sensitive GSK-3 inhibition and late VEGF release mediate hypoxia – dependent epithelial mesenchymal transition in and increased invasiveness in human HepG2 cells 63
Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications 63
Multiple molecular mechanisms sustain hypoxia - dependent epithelial - mesenchymal transition and increased invasiveness in human cancer cells 63
SERPINB3 induces epithelial-mesenchymal transition. 61
Epithelial-Mesenchymal Transition: From Molecular Mechanisms, Redox Regulation to Implications in Human Health and Disease 60
Silencing of Bcl-2 by specific siRNA sensitizes human-activated hepatic stellate cells to TNF – induced apoptosis 59
Oncostatin M, a novel profibrogenic mediator, is involved in the progression non-alcoholic fatty liver disease and stimulates migration of myofibroblasts 58
Hepatic myofibroblasts in liver fibrogenesis 57
Hepatic angiogenesis and fibrogenesis in the progression of chronic liver diseases 57
VEGF and Angiopoietin-1 as chemotactic factors for activated human hepatic stellate cells 54
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 53
Hypoxia up-regulates SERPINB3 in hepatic cancer cells: a HIF-2α associated event related to invasiveness and epithelial to mesenchymal transition. 52
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells 52
SERPIN-B3 INDUCES HIF2α NUCLEAR TRANSLOCATION IN HEPATIC CANCER CELLS: A PARACRINE LOOP ABLE TO AFFECT CANCER CELL BEHAVIOUR 51
Hypoxia up-regulates serpin B3 in HepG2 cells: a HIF-2α associated and redox sensitive event related to invasiveness and epithelial to mesenchymal transition 50
Iperespressione di Bcl-2 in cellule stellate epaticheumane: un meccanismo di sopravvivenza pro-fibrogenico in corso di epatopatie croniche 49
VEGF and angiopoietin-1 as hypoxia-inducible, autocrine and paracrine chemotactic factors for human hepatic stellate cells 49
SERPINB3 AND YAP INTERPLAY INCREASES MYC ONCOGENIC ACTIVITY 49
ERK5 is overexpressed in experimental liver injury and in hepatocellular carcinoma (HCC), and is modulated by soluble factors in HCC cells. 42
SERPIN-B3 INDUCES HIF2a NUCLEAR TRANSLOCATION IN HEPATIC CANCER CELLS: A PARACRINE LOOP ABLE TO AFFECT CANCER CELL BEHAVIOUR 42
ONCOSTATIN M IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND CAN INDUCE EPITHELIAL TO MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS IN HEPATIC CANCER CELLS BY TWO DISTINCT MECHANISMS 42
Serpin B3 and YAP interplay increase Myc oncogenic increase 41
Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis 41
Totale 14.102
Categoria #
all - tutte 36.087
article - articoli 0
book - libri 0
conference - conferenze 13.367
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.376 0 0 0 0 102 220 234 170 214 219 122 95
2020/20211.629 154 145 130 104 139 117 136 84 154 151 116 199
2021/20221.733 172 111 53 160 114 72 99 87 120 108 337 300
2022/20232.140 220 197 60 252 168 468 165 157 202 47 121 83
2023/20241.805 153 189 105 81 272 207 163 172 23 132 129 179
2024/20251.335 79 213 215 268 560 0 0 0 0 0 0 0
Totale 14.565